S100A8 and ischemic stroke: Elevated levels of S100A8/A9 in venous blood samples have been correlated with functional outcome and increased 3-months mortality in patients with mild to moderate AIS suggesting its potential as a prognostic biomarker in human ischemic stroke (Marta-Enguita et al., 2021; Guo et al., 2020).